Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Human T-lymphotropic virus 2

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44341   clinical trials with a EudraCT protocol, of which   7370   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    211 result(s) found for: Human T-lymphotropic virus 2. Displaying page 4 of 11.
    « Previous 1  2  3  4  5  6  7  8  9  Next» Last»»
    EudraCT Number: 2014-001193-34 Sponsor Protocol Number: STRIB-PEP Start Date*: 2014-07-16
    Sponsor Name:Fundació Clínic per a la recerca biomèdica
    Full Title: COMPARISON OF TWO ANTIRETROVIRAL ALTERNATIVE COMBINATIONS IN HIV-1 POST-EXPOSURE PROPHYLAXIS: TENOFOVIR+EMTRICITABINE (TRUVADA®) + LOPINAVIR/RITONAVIR (KALETRA®) VS TENOFOVIR+EMTRICITABINA+ COBICIS...
    Medical condition: Prophilaxis VIH infecction post accidental exposition (PPE)
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004862 10020160 HIV disease LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-003940-50 Sponsor Protocol Number: ANRS HB 03 Start Date*: 2007-01-30
    Sponsor Name:ANRS
    Full Title: ESSAI RANDOMISE MULTICENTRIQUE DE PHASE III COMPARANT L’IMMUNOGENICITE ET LA TOLERANCE DE TROIS SCHEMAS DE VACCINATION CONTRE LE VIRUS DE L’HEPATITE B CHEZ DES PATIENTS INFECTES PAR LE VIH AYANT DE...
    Medical condition: L'essai ANRS HB 03 vise à comparer l’immunogénicité de trois stratégies de vaccination anti-VHB chez des patients infectés par le VIH ayant un taux de CD4 supérieurs à 200 par mm3.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10020161 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2008-006049-26 Sponsor Protocol Number: A5271038 Start Date*: 2009-04-29
    Sponsor Name:Pfizer Inc., 235 East 42nd Street, New York, NY 10017
    Full Title: A PHASE 2B/3 OPEN-LABEL ROLLOVER STUDY FOR SUBJECTS DISCONTINUING FROM THE UK-453,061 PROTOCOLS FOR THE TREATMENT OF HIV-1 INFECTED SUBJECTS
    Medical condition: HIV-1
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004862 10068341 HIV-1 infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) DE (Prematurely Ended) PL (Completed) ES (Prematurely Ended) IT (Prematurely Ended) FR (Completed)
    Trial results: View results
    EudraCT Number: 2006-005962-38 Sponsor Protocol Number: ANRS 136 Start Date*: 2007-01-23
    Sponsor Name:Agence nationale de recherches sur le sida et les hépatites virales ANRS
    Full Title: Essai randomisé de non-infériorité comparant la capacité à maintenir le succès virologique d’une stratégie de traitement simplifié par une monothérapie d’inhibiteur de protéase boosté, le darunavir...
    Medical condition: Infection VIH
    Disease: Version SOC Term Classification Code Term Level
    9.0 10020161 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2007-000162-20 Sponsor Protocol Number: ANRS 138 Start Date*: 2007-06-20
    Sponsor Name:Agence nationale de recherches sur le sida et les hépatites virales. ANRS
    Full Title: Essai randomisé de non-infériorité comparant une stratégie de maintien du traitement antirétroviral en cours à une stratégie de substitution de l’enfuvirtide par un inhibiteur de l’intégrase (MK 05...
    Medical condition: Infection VIH
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020161 HIV infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2016-004656-30 Sponsor Protocol Number: MK-1439-052 Start Date*: 2016-11-16
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: A Study of the Comparative Bioavailability of Two Second-Generation Investigational Pediatric Oral Granule Formulations of MK-1439 Compared to the Adult Formulation. Additional PIP decision nu...
    Medical condition: HIV-1 Infection
    Disease: Version SOC Term Classification Code Term Level
    19.0 10021881 - Infections and infestations 10020161 HIV infection PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2012-002515-25 Sponsor Protocol Number: LLC-TEL-2012-1 Start Date*: 2012-09-10
    Sponsor Name:Luis López Cortes - FISEVI
    Full Title: Pharmacokinetic interactions between Telaprevir and not powered Atazanavir with ritonavir in co-infected patients with HIV and HCV genotype 1 in treatment for chronic liver disease by HCV
    Medical condition: HIV–HCV co-infected patients
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10020161 HIV infection PT
    14.1 10021881 - Infections and infestations 10065949 HCV coinfection LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2016-004392-41 Sponsor Protocol Number: MK-1439A-054 Start Date*: 2016-11-21
    Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
    Full Title: A Study of the Comparative Bioavailability of Two Investigational Pediatric Oral Granule Formulations of Lamivudine and Tenofovir Compared to the Adult Marketed Formulations. Other PIP decision ...
    Medical condition: HIV-1 infection
    Disease: Version SOC Term Classification Code Term Level
    19.0 10021881 - Infections and infestations 10020161 HIV infection PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2018-001358-84 Sponsor Protocol Number: 1708212 Start Date*: 2018-10-12
    Sponsor Name:CHU de Saint Etienne
    Full Title: Bone, Inflammation, Gut and Renal Biomarkers in Antiretroviral Naïve HIV-1 positive subjects commencing Antiretroviral Therapy
    Medical condition: HIV-positive subjects initiating antiretroviral therapy
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004862 10020160 HIV disease LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-005973-21 Sponsor Protocol Number: RTLP Start Date*: 2013-11-20
    Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA
    Full Title: A prospective, randomized, open-label trial of two abacavir/lamivudine based regimen (ABC/3TC + darunavir/ritonavir or ABC/3TC + raltegravir) in late presenter naïve patients (with CD4 count <200 c...
    Medical condition: Advanced HIV disease, defined as a CD4 cell count <200 cells/µL or the presence of an AIDS-defining event.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10020161 HIV infection PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-005591-33 Sponsor Protocol Number: HIVCOBOC-RGT Start Date*: 2013-07-29
    Sponsor Name:Universitätsklinik f. Innere Medizin III, Medizinische Universität Wien
    Full Title: Response-guided triple therapy using boceprevir in combination with PEGIFN/RBV in HIV/HCV coinfected patients
    Medical condition: Chronic genotype 1 HCV coinfection in HIV-positive patients.
    Disease: Version SOC Term Classification Code Term Level
    16.0 10021881 - Infections and infestations 10065949 HCV coinfection LLT
    16.0 10021881 - Infections and infestations 10020161 HIV infection PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: AT (Completed)
    Trial results: View results
    EudraCT Number: 2016-003796-22 Sponsor Protocol Number: IFCT-1602 Start Date*: 2017-09-22
    Sponsor Name:IFCT
    Full Title: Immunotherapy by Nivolumab after prior Chemotherapy for HIV+ patients with Advanced non-small cell lung cancer (NSCLC): IFCT-CHIVA2 phase IIa trial
    Medical condition: Advanced non small cell lung cancer in VIH+ patient
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10041068 Small cell lung cancer extensive stage PT
    20.0 10021881 - Infections and infestations 10020161 HIV infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2008-004970-41 Sponsor Protocol Number: ANRS 12 180 Start Date*: 2008-12-17
    Sponsor Name:Agence nationale de recherches sur le sida et les hépatites virales. ANRS.
    Full Title: Phase II open-label randomized multicenter trial to compare the efficacy and safety of two different doses of raltegravir and efavirenz, all in combination with tenofovir and lamivudine, in naive H...
    Medical condition: HIV-1 Infection and tuberculosis
    Disease: Version SOC Term Classification Code Term Level
    11.0 10020161 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: View results
    EudraCT Number: 2013-003527-11 Sponsor Protocol Number: ING200336 Start Date*: 2014-05-13
    Sponsor Name:ViiV Healthcare, S.L.
    Full Title: ING200336: A Prospective, Interventional Pharmacokinetic and Safety Study of DTG/ABC/3TC in Pregnant Women.
    Medical condition: HIV-infection
    Disease: Version SOC Term Classification Code Term Level
    17.0 100000004862 10020160 HIV disease LLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2010-021002-38 Sponsor Protocol Number: ATADAR Start Date*: 2010-11-10
    Sponsor Name:Fundació Clínic per a la Recerca Biomèdica
    Full Title: Estudio sobre los efectos metabólicos de atazanavir/ritonavir versus darunavir/ritonavir en combinación con tenofovir/emtricitabina en pacientes infectados por el VIH-1 sin tratamiento previo: ensa...
    Medical condition: Tratamiento para pacientes infectados por el VIH-1 sin tratamiento previo
    Disease: Version SOC Term Classification Code Term Level
    13 10020160 Enfermedad por VIH LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-002383-34 Sponsor Protocol Number: TMC114HIV3017 Start Date*: 2008-10-09
    Sponsor Name:JANSSEN-CILAG
    Full Title: A randomised, controlled, open-label trial to compare brachial artery reactivity and cardiovascular risk of a treatment simplification by darunavir/ritonavir (DRV/r) 800/100 mg O.D. versus a triple...
    Medical condition: HIV-1 Infection
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020161 HIV infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-006912-39 Sponsor Protocol Number: PHPC-02 Start Date*: 2009-01-26
    Sponsor Name:VIROSTATICS, SRL
    Full Title: ANTIRETROVIRAL-SPARING CONCEPT: AN EXPLORATORY PHASE II, RANDOMIZED, SINGLE BLIND PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF THERAPEUTIC IMMUNIZATION ON THE QUANTITY OF HIV-SPECIFIC T CE...
    Medical condition: HIV-1infected patients
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020161 HIV infection LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-004693-29 Sponsor Protocol Number: IFNHIV Start Date*: 2011-11-15
    Sponsor Name:ISTITUTO NAZIONALE DELLE MALATTIE INFETTIVE LAZZARO SPALLANZANI
    Full Title: Pegylated interferon alfa-2a USE FOR CONTROLLING virological rebound after suspension of antiretroviral treatment IN PATIENTS WITH CHRONIC HIV INFECTION
    Medical condition: HIV-1 infected patients
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10020161 HIV infection PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2010-018326-39 Sponsor Protocol Number: CB-2010-01 Start Date*: 2010-04-20
    Sponsor Name:Department of Genito-Urinary Medicine and Infectious Diseases
    Full Title: An open-label, randomised pilot study comparing the efficacy, safety and tolerability of raltegravir with protease inhibitor-based therapy in treatment-naïve, HIV/Hepatitis C co-infected injecting ...
    Medical condition: HIV-1/Hepatitis C co-infected patients
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021881 - Infections and infestations 10020161 HIV infection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IE (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-009776-13 Sponsor Protocol Number: ANRS140 Start Date*: 2009-07-20
    Sponsor Name:Agence nationale de recherches sur le sida et les hépatites virales. ANRS.
    Full Title: Essai clinique comparant l’efficacité et la tolérance de deux stratégies thérapeutiques de maintenance: monothérapie par lopinavir/ritonavir ou trithérapie en comprimé unique quotidien par efaviren...
    Medical condition: Infection VIH
    Disease: Version SOC Term Classification Code Term Level
    11.0 10020161 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    « Previous 1  2  3  4  5  6  7  8  9  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri Jun 13 00:02:39 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA